Timothy Lee

EDUCATION

College / University

University of the Philippines Diliman

Highest Degree

Bachelor of Science

Major Subjects

Molecular Biology and Biotechnology

Lee

Country

Philippines

Lab Experience

Molecular biology: nucleic acid & protein extraction, qPCR, AGE, SDS-PAGE, PCR, RE digestion, site-directed mutagenesis, Gibson cloning, gel DNA extraction, western blot, heat shock transformation, UCC preparation, ELISA, Immunohistochemistry, EMSA, Percoll Gradient
Cell culture & Animal handling: routine mammalian cell maintenance, transfection, establishment of primary cell cultures, fluorescence imaging, karyotyping, cancer hallmark assays (e.g. migration, proliferation, apoptosis), dual luciferase assay, flow cytometry (including cytokine stimulation and intracellular cytokine staining), mice dissection to isolate immunocyte niches (spleen, lymph nodes), mice genotyping

Projects / Research

  • 2023 – 2025: Thesis, “Beyond KRAS And BRAF: Differential Oncogenic Effects of the Novel MEK1 V154I And E285D Mutations”, National Institute of Molecular Biology and Biotechnology, University of the Philippines Diliman, Philippines
  • 2024 – 2025: Drug Discovery, “Confirmatory and orthogonal assays to eliminate artefactual drug bioactivities”, National Institute of Molecular Biology and Biotechnology, University of the Philippines Diliman, Philippines
  • 2025: Summer Internship Project, “Small Intestinal Eosinophils inhibit ILC2 expansion via IL-27”, Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan

Scholarships / Awards

2025 – 2026: Stipend by the International Max Planck Research School
2025: Stipend by the Institute of Molecular Biology, Academia Sinica
2024: Summa Cum Laude, University of the Philippines Diliman
2024: 2nd Place, Young Scientist Forum, Philippine Society for Biochemistry and Molecular Biology
2022 – 2024: Education for Development Scholarship Program

SCIENTIFIC INTERESTS AND GOALS

I aspire to one day specialize in therapeutic approaches for many of today’s clinically important pathologies. While in the past much of my work has been on cancer, the field of immunology has recently piqued my interest, as I currently do research on immunocytes in understudied microenvironments such as the small intestine. In the future, I am keen to explore how we might develop more effective interventions guided by our understanding of disease on the molecular level, hopefully paving the way for better patient outcomes and overall improving public health.